Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

Name: Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
Published: 2019
License: Public Domain

National Cancer Institute (NCI) · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

extensive stage lung small cell carcinoma, extrapulmonary small cell neuroendocrine carcinoma, limited stage lung small cell carcinoma, platinum-resistant lung small cell carcinoma, platinum-sensitive lung small cell carcinoma, recurrent lung small cell carcinoma, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

Related documents